Mary Wilson
Well-known member
Sleep Medicine Reviews
Available online 8 September 2020, 101382
In Press, Journal Pre-proof
Michelle A.MillerPhD[SUP]a[/SUP]Francesco P.Cappuccio[SUP]a[/SUP][SUP]b[/SUP]
https://doi.org/10.1016/j.smrv.2020.101382
Summary
The aims of the study were to review the rapidly emerging COVID-19 literature to determine (a) the relationship between obstructive sleep apnoea (OSA) and adverse COVID-19 outcomes and, (b) potential causal mechanisms (c) what effect COVID-19 has had on OSA diagnosis and (d) what effect COVID-19 has had on treatment and management of OSA during this period. PubMed was systematically searched up to 020620. Studies were included if they had examined the relationship between COVID-19 and OSA. Studies were included that were in English and had the full text available. The findings from this study suggest that many of the risk factors and co-morbidities associated for OSA which include obesity, hypertension and diabetes mellitus are associated with poor COVID-19 outcomes. There are plausible mechansims by which OSA may independently increase one’s risk of morbidity and mortality associated with COVID-19 and data from the newly published CORONADO study suggests that OSA treated patients may be at increased risk of death from COVID-19. It is clear that the pandemic has had a major effect on the treatment management and diagnosis of OSA and moving forward it may be necessary to explore new diagnosis and treatment pathways for these individuals.
https://www.sciencedirect.com/science/article/pii/S1087079220301258
Available online 8 September 2020, 101382
In Press, Journal Pre-proof
Michelle A.MillerPhD[SUP]a[/SUP]Francesco P.Cappuccio[SUP]a[/SUP][SUP]b[/SUP]
https://doi.org/10.1016/j.smrv.2020.101382
Summary
The aims of the study were to review the rapidly emerging COVID-19 literature to determine (a) the relationship between obstructive sleep apnoea (OSA) and adverse COVID-19 outcomes and, (b) potential causal mechanisms (c) what effect COVID-19 has had on OSA diagnosis and (d) what effect COVID-19 has had on treatment and management of OSA during this period. PubMed was systematically searched up to 020620. Studies were included if they had examined the relationship between COVID-19 and OSA. Studies were included that were in English and had the full text available. The findings from this study suggest that many of the risk factors and co-morbidities associated for OSA which include obesity, hypertension and diabetes mellitus are associated with poor COVID-19 outcomes. There are plausible mechansims by which OSA may independently increase one’s risk of morbidity and mortality associated with COVID-19 and data from the newly published CORONADO study suggests that OSA treated patients may be at increased risk of death from COVID-19. It is clear that the pandemic has had a major effect on the treatment management and diagnosis of OSA and moving forward it may be necessary to explore new diagnosis and treatment pathways for these individuals.
https://www.sciencedirect.com/science/article/pii/S1087079220301258